Samik Pharm Co Ltd
KOSDAQ:014950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Samik Pharm Co Ltd
KOSDAQ:014950
|
KR |
|
D
|
Downer EDI Ltd
F:DNE
|
AU |
|
Northern Ocean Ltd
F:4JO
|
BM |
|
U
|
Ultralife Corp
F:ULB
|
US |
|
Clara Resources Australia Ltd
F:0H8A
|
AU |
|
P
|
Pak Datacom Ltd
KAR:PAKD
|
PK |
|
ASR Nederland NV
F:A16
|
NL |
|
LDR Capital Property Fund I
ASX:LED
|
AU |
|
U
|
Unilever Indonesia Tbk PT
XMUN:UTG
|
ID |
|
Cadoux Ltd
F:SDL0
|
AU |
|
Lassonde Industries Inc
F:0OO
|
CA |
|
P
|
Prothena Corporation PLC
F:0PT
|
IE |
|
Marechale Capital PLC
LSE:MAC
|
UK |
|
M
|
MocoMSys Inc
KOSDAQ:333050
|
KR |
|
J
|
Julius Baer Gruppe AG
F:JGE
|
CH |
Shareholder Yield
Current shareholder yield for Samik Pharm Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Samik Pharm Co Ltd
| Average Annual Return | -42.02% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -82% |
| Market Capitalization | 81.5B KRW |
| Shares Outstanding | 10 010 000 |
| Percentage of Shares Shorted |
N/A
|
